Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CVSI |
---|---|---|
09:32 ET | 12650 | 0.0375 |
10:04 ET | 2000 | 0.03875 |
10:15 ET | 1300 | 0.03875 |
10:18 ET | 1000 | 0.03875 |
10:20 ET | 13000 | 0.03875 |
10:22 ET | 15200 | 0.037625 |
10:24 ET | 12000 | 0.03875 |
10:27 ET | 4600 | 0.04 |
11:03 ET | 4000 | 0.04 |
12:24 ET | 200 | 0.03925 |
01:24 ET | 154000 | 0.0385 |
01:33 ET | 62930 | 0.0377 |
01:56 ET | 900 | 0.03885 |
02:25 ET | 1000 | 0.03885 |
02:32 ET | 450 | 0.038505 |
02:39 ET | 15250 | 0.038 |
02:41 ET | 5263 | 0.0387 |
02:54 ET | 5000 | 0.0399 |
03:46 ET | 1000 | 0.039 |
03:50 ET | 1000 | 0.038 |
04:00 ET | 1545 | 0.038 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CV Sciences Inc | 7.1M | -2.5x | -25.43% |
NovaBay Pharmaceuticals Inc | 3.3M | 0.0x | --- |
Evofem Biosciences Inc | 983.2K | 0.0x | --- |
Sonoma Pharmaceuticals Inc | 3.8M | -0.6x | --- |
ImmuCell Corp | 32.9M | -7.7x | --- |
GSRX Industries Inc | 80.0 | 0.0x | --- |
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.1M |
---|---|
Revenue (TTM) | $15.6M |
Shares Outstanding | 184.3M |
CV Sciences Inc does not pay a dividend. | |
Beta | 0.62 |
EPS | $-0.02 |
Book Value | $0.02 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -15.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.